Companies: 10,795·Total market cap: $144.5T
Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAINASDAQHealthcare● Active
$16.14
$-0.35(-2.12%)
Market Cap$4.6B
P/E Ratio—
52W High$42.5
52W Low$14.19
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Caris Life Sciences, Inc. (CAI) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CAI · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.56cai eps ttm · cai earnings per shareEarnings history
PE Ratio (TTM)—cai pe ratio ttm · cai price to earningsPE Ratio deep dive
Revenue (TTM)$907.3Mcai revenue ttm · cai annual revenueFull revenue history
Dividend YieldNo Dividenddoes cai pay dividends · cai dividend yieldDividend history
Shares Outstanding1.67Bcai shares outstanding · cai floatShares outstanding history
Next EarningsAug 11, 2026Est.cai earnings date · cai next earningsEarnings history

Explore Caris Life Sciences, Inc. Data

cai stock data · financials
Market Cap$4.6Bcai market cap · cai valuation
Analyst Forecast$29 · Buy
DividendsNo Dividenddoes caris life sciences, inc. pay dividends · cai dividend yield
Revenue$812.0M+96.97%caris life sciences, inc. annual revenue · cai revenue
EarningsEPS $-1.90+29.63%cai earnings · cai eps
PE Ratio—cai pe ratio · cai price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$812.0M▲ +96.97% YoY
202320242025
caris life sciences, inc. revenue · cai revenue 2025
FY 2025Net Income-$538.0M▼ 90.84% YoY
202320242025
caris life sciences, inc. net income · cai profit 2025
FY 2025EPS$-1.90▲ +29.63% YoY
202320242025
cai eps · caris life sciences, inc. earnings per share 2025
TTM:Revenue: $907.3MNet Income: $34.0MEPS: $-1.56View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis cai a buy · cai analyst rating
Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$21.00Low
$16.14Current
$28.60Avg Target77.20% upside
$38.00High
cai price target · cai 12 month forecast

Total: 7 · Buy rate: 85.7%

The CAI analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $28.60, representing +77.20% upside from the current price of $16.14.

Stock Performance

Full History
1D-4.57%
1W+2.36%
1M+2.11%
3M-11.30%
YTD-38.88%
1Y-41.11%
5Y-41.11%

About Caris Life Sciences, Inc.

CEODavid Dean Halbert
IPO DateJun 18, 2025
Employees1,769
CountryUS
Websitecarislifesciences.com

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and intern…

BiotechnologyHealthcareNASDAQUS

what is caris life sciences, inc. · cai stock overview · caris life sciences, inc. company profile · who is caris life sciences, inc. ceo · cai NASDAQ · caris life sciences, inc. headquarters · caris life sciences, inc. business segments

About Stock Overview & Key Data

Caris Life Sciences, Inc. (CAI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 18, 2025. As of the latest trading session, CAI stock price is $16.14, with a market capitalization of $4.6B. The stock has returned -41.11% over the past 12 months and -38.88% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Caris Life Sciences, Inc. stock is Buy, with an average 12-month price target of $28.60. In fiscal year 2025, Caris Life Sciences, Inc. reported revenue of $812.0M and net income of -$538.0M. For detailed data — including Caris Life Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Caris Life Sciences, Inc. (CAI) stock price is $16.14. The stock is traded on NASDAQ under the ticker symbol CAI. The 52-week range is $14.19 – $42.50.

CAI stock priceCAI quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice